What Is Biomarker-Driven Therapy in Modern Oncology?
Biomarker-driven therapy is a precision oncology approach where cancer treatment is selected based on specific molecular characteristics of a tumor […]
Precision Oncology
Geriatric & AYA Oncology
Individualizing Cancer Treatment in the Elderly and Young Adults
Cancer treatment should not be determined by age alone. Elderly patients require physiologic assessment beyond chronological age, while adolescents and
Disease-Specific Deep Dives
Molecular Subtypes Across Common Cancers: Why Biology Matters More Than Stage
Cancer stage describes where the disease has spread. Molecular subtypes in cancer explains how the cancer behaves. In modern oncology,
Treatment Strategy & Second Opinions
How Structured Second Opinions Improve Cancer Treatment Decisions
A structured second opinion in oncology is a systematic re-evaluation of diagnosis, staging, pathology, molecular data, and treatment sequencing. It
Cancer Genetics & Hereditary Risk
When and Why Genetic Testing Matters in Cancer Treatment and Prevention
Genetic testing in cancer evaluates inherited (germline) mutations that may influence both treatment decisions and long-term risk assessment. It helps
Precision Oncology
The Foundations of Precision Oncology in Modern Cancer Care
Precision oncology is a structured approach to cancer treatment that integrates tumor biology, molecular profiling, and patient-specific clinical factors to
Precision Oncology
How Molecular Profiling Influences Treatment Decisions in Lung Cancer
Molecular profiling in lung cancer identifies specific genetic alterations within a tumor that determine which therapy is most biologically appropriate.